Ventricular Tachycardia - Pipeline Review, H2, Pharmaceutical 2016
"Ventricular Tachycardia - Pipeline Review, H2 2016" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect. Description- Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia - Pipeline Review, H2 2016, provides an overview of the Ventricular Tachycardia (Cardiovascular) pipeline landscape. Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia include dizziness, fainting, fatigue, chest pain and shortness of breath. Causes include cardiomyopathy, ischemic heart disease and heart failure. Risk factors include age, family history and medical history. Treatment includes antiarrhythmic medication. Get Sample Report With TOC @ http://www.researchmoz.us/enquiry.php?type=S&repid=896034 Report Highlights Global Markets Direct's Pharmaceutical and Healthcare late